Jacksonville, United States
xLM - Continuous Validation offers a revolutionary approach to GxP Validation. The company's slogan "There is a better way to do GxP Validation 🚀 No more manual testing 👍 No more heavy validation spending" encapsulates their mission to transform the validation process in the life sciences industry. Founded in 2015 and headquartered in the United States, xLM targets Information Technology and SaaS sectors.
The company's main focus lies in reducing GxP validation costs, compressing timelines, and bolstering compliance. Its Continuous Validation managed services cater to a wide range of clients, from multinational pharmaceutical companies to nimble bio-tech and medical device companies. By leveraging their Continuous Validation Platform, xLM automates the software validation lifecycle, eliminating manual testing through intelligent testing bots.
With a portfolio featuring work with renowned platforms and apps including AWS, Microsoft Azure, GCP, Veeva Apps, Serialization (TraceLink, Axway), QMS, ITSM, LIMS, and ERP, xLM offers to reduce GxP validation costs by more than 75% and compress timelines by over 50%. Moreover, their managed services exceed the current expectations of the FDA's CSA, offering unprecedented outcomes such as a workload reduction of over 90%, 100% regression testing at a click of a button, expedited software changes implementation, painless new software releases, and a test coverage surpassing manual testing by more than 10x.
While no specific information about their last investment or investors is available, xLM - Continuous Validation stands as an intriguing investment opportunity in the realm of life sciences and compliance technology. With its disruptive approach, proven outcomes, and potential for industry-wide adoption, xLM presents an attractive proposition for venture capitalists looking to tap into the digital transformation of validation processes within the life sciences sector.
